This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Life science industry thought leaders from
Medidata Solutions (NASDAQ: MDSO) will be addressing the changing world of clinical trials at numerous European events in the coming weeks. From Big Data’s impact on R&D to the role of cloud computing in the clinical development enterprise to data-based analytics and decision making, Medidata’s team will discuss new approaches to tackling today’s pharma industry challenges.
“The European pharma community is continuing to react to significant financial pressures, and the resolve to reduce timelines, reduce costs and maximize delivery is higher than ever,” said Richard Young, director, regional sales, EMEA at Medidata Solutions. “Medidata is leading this crusade, delivering solutions to sponsors that help them meet—and exceed—these goals. By taking a leadership role in discussing how technology can optimize the entire clinical paradigm, Medidata is contributing to the faster, more effective delivery of medicines in Europe and across the globe.”
About Medidata Solutions WorldwideMedidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding to business analytics. Our diverse life science customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics.